New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.
Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.
The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.
Bayer has sought directions to the customs authorities to seize and confiscate the consignment.
Bihar Election 2025: RJD Tops Vote Share But Slips To Third Place In Seat Tally
PIB Debunks Fake News On IAF Plane Crash By Pakistani Propaganda Accounts On Social Media
Veteran Actor Dharmendra To Celebrate 90th Birthday? Hema Malini & Family Make Plans As His Health Improves
'Khasdar Krida Mahotsav 2025' Enters Day 14 With High-Octane Sports Events Across North Mumbai
